YorkBridge Wealth Partners’s Enzo Biochem, Inc. ENZ Stock Holding History

YorkBridge Wealth Partners’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-279	Closed	-$1K	–	681
2019 Q2	$1K	Hold	279	–	–	﹤0.01%	738
2019 Q1	$1K	Hold	279	–	–	﹤0.01%	738
2018 Q4	$1K	Hold	279	–	–	﹤0.01%	726
2018 Q3	$1K	Hold	279	–	–	﹤0.01%	742
2018 Q2	$1K	Hold	279	–	–	﹤0.01%	836
2018 Q1	$2K	Hold	279	–	–	﹤0.01%	801
2017 Q4	$2K	Hold	279	–	–	﹤0.01%	822
2017 Q3	$3K	Hold	279	–	–	﹤0.01%	758
2017 Q2	$3K	Hold	279	–	–	﹤0.01%	754
2017 Q1	$2K	Hold	279	–	–	﹤0.01%	789
2016 Q4	$2K	Buy	+279	New	+$1.78K	﹤0.01%	784

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

YorkBridge Wealth Partners's ENZ Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of Enzo Biochem, Inc. (ENZ) in Q3 2019, closing a stake of 279 shares — an estimated $1K sold.

YorkBridge Wealth Partners first reported a position in ENZ in Q4 2016 and held it in 11 quarters. The position peaked at $3K in Q3 2017. 87 funds tracked by Wall St. Rank hold ENZ as of Q3 2019.

YorkBridge Wealth Partners reported no remaining Enzo Biochem, Inc. position as of Q3 2019 after selling out during the quarter.
YorkBridge Wealth Partners sold 279 Enzo Biochem, Inc. shares in Q3 2019, an estimated $1K.
YorkBridge Wealth Partners first reported a position in Enzo Biochem, Inc. in Q4 2016 and held it in 11 quarters.
YorkBridge Wealth Partners's Enzo Biochem, Inc. position peaked at $3K in Q3 2017.
87 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.